DHL to acquire 100% of CRYOPDP, a leading specialty courier providing logistics services for clinical trials, biopharma, and cell & gene therapies. This acquisition enhances DHL's capabilities in ...

CRYOPDP is a leading specialty courier providing services for clinical trials, biopharma, and cell & gene therapies.

Headquartered just outside Paris, Cryopdp handles more than 600,000 shipments per year, with customers and patients in over 135 countries. DHL said the acquisition would enhance its capabilities ...

DHL is set to acquire U.S. pharmaceutical logistics firm Cryopdp for a three-digit million-euro sum as part of the German company's efforts to expand in the pharma sector, a source familiar with the ...

DHL said a major new investment will help double revenue for health care logistics by 2030 while FedEx says its technology ...

Dhl is enhancing its healthcare logistics capabilities in the United States through the acquisition of Cryopdp, a company ...

DHL Group already has an established Life Sciences and Healthcare business, contributing over EUR 5 billion in global revenue in 2024. Building on this foundation, the acquisition of CRYOPDP marks ...

We’re sorry, we are currently experiencing some issues, please try again later. Our team is working diligently to resolve the issue. Thank you for your patience and ...

DHL to acquire 100% of CRYOPDP, a leading specialty courier providing logistics services for clinical trials, biopharma, and cell & gene therapies. This acquisition enhances DHL's capabilities in ...